Tuesday, 21 November 2017
Latest news
Main » (DGX) Shares now down at $92.05 Quest Diagnostics Reports Third Quarter…

(DGX) Shares now down at $92.05 Quest Diagnostics Reports Third Quarter…

21 October 2017

Connable Office reported 7,849 shares or 0.08% of all its holdings. Its down 3.49% from 2.77 million shares previously.

KBR, Inc. has a beta of 0.59, offering the possibility of a higher rate of return, but also posing more risk.

The stock increased 0.60% or $0.3 during the last trading session, reaching $50.4. Its share price has decline -34.36% in three months and is down -1.40% for the last five trades. It is down 39.04% since October 20, 2016 and is uptrending. It has outperformed by 57.19% the S&P500. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and seven have given a buy rating to the stock. Therefore 57% are positive.

More news: Starr returning to Lambeau Field this weekend

It is now trading at $92.05 which is slightly below $98.89, the 50 day moving average and quite a bit below the 200 day moving average of $104.64.

A number of other equities research analysts have also recently weighed in on DGX. On September 28 Credit Suisse kept the stock rating at "Neutral" and raised the price target to $99.00 from $72.00. Argus Research initiated it with "Hold" rating and $102 target in Friday, May 12 report. Quest Diagnostics's payout ratio is now 34.04%. (The) downgraded Quest Diagnostics from a "conviction-buy" rating to a "buy" rating and reduced their price objective for the company from $121.00 to $113.00 in a research report on Tuesday, October 10th. The rating was upgraded by Evercore on Monday, November 7 to "Buy". Canaccord Genuity set a $90.00 price target on shares of Quest Diagnostics and gave the company a "buy" rating in a report on Monday. The stock of Quest Diagnostics Inc (NYSE:DGX) has "Hold" rating given on Tuesday, June 27 by Jefferies.

Since June 6, 2017, it had 0 insider purchases, and 1 sale for $324,520 activity. Legal & General Group Plc now owns 716,279 shares of the company's stock valued at $51,184,000 after buying an additional 13,937 shares during the last quarter. Financial Architects Inc now owns 1,666 shares of the medical research company's stock valued at $185,000 after buying an additional 88 shares in the last quarter. Therefore 35% are positive. PulteGroup had 47 analyst reports since September 11, 2015 according to SRatingsIntel. The stock of PulteGroup, Inc. The rating was maintained by Mizuho on Friday, October 21 with "Neutral". The stock has "Hold" rating by Topeka Capital Markets on Thursday, May 26. The stock has "Overweight" rating by Barclays Capital on Friday, January 6. Bank of America upgraded the stock to "Buy" rating in Tuesday, July 25 report. RBC Capital Markets maintained PulteGroup, Inc. The rating was upgraded by Goldman Sachs to "Buy" on Monday, December 12. Following the transaction, the chairman now directly owns 220,049 shares in the company, valued at $23,800,499.84. Stockholders of record on Tuesday, October 3rd were paid a $0.45 dividend. Its down 0.05, from 1.04 in 2017Q1. 56 funds opened positions while 130 raised stakes. Amf Pensionsforsakring Ab reported 297,061 shares. Hartwell J M Partnership holds 0.12% or 22,850 shares in its portfolio. Moreover, Independent Portfolio Consultants Inc has 0% invested in Deere & Company (NYSE:DE). Washington State Bank reported 1,168 shares or 0.03% of all its holdings. Stevens First Principles Advisors holds 2.74% in PulteGroup, Inc. Brookstone Mgmt has 0.03% invested in Timken Co (NYSE:TKR) for 6,147 shares. Franklin Res invested in 0.01% or 519,732 shares. Axa has invested 0.01% in Timken Co (NYSE:TKR). Sumitomo Mitsui Asset reported 10,949 shares or 0.02% of all its holdings. 733,294 shares of the company were exchanged. Waters Parkerson Communication Ltd Liability Corp holds 4,725 shares. (NYSE:PHM) for 14,356 shares.

More news: Steyer launches multimillion-dollar campaign to impeach Trump

Quest Diagnostics Incorporated, launched on September 20, 1996, is a provider of diagnostic information services. The company has market cap of $3.94 billion. The Firm operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. It has a 18.64 P/E ratio. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs).

Investors sentiment increased to 1 in Q2 2017. Its down 0.05, from 1.04 in 2017Q1.

Several large investors have recently added to or reduced their stakes in DGX. 78 funds opened positions while 158 raised stakes. Carret Asset Management Lc invested in 7,889 shares. Amalgamated Fincl Bank has 15,417 shares. Calamos Advsrs Llc owns 38,439 shares or 0.03% of their USA portfolio. Massachusetts-based Panagora Asset has invested 0.04% in Quest Diagnostics Inc (NYSE:DGX). 1St Glob holds 9,088 shares or 0.12% of its portfolio.

More news: Latest Analysts Reports: Winnebago Industries, Inc. (WGO), GameStop Corp. (GME)

Balyasny Asset Management LLC decreased its position in shares of Quest Diagnostics Incorporated (NYSE:DGX) by 97.0% during the second quarter, according to the company in its most recent filing with the SEC. Quest Diagnostics's dividend payout ratio is now 36.29%. Gam Ag reported 67,506 shares. Fin Advantage invested 2.81% in Quest Diagnostics Inc (NYSE:DGX). Perkins Capital Mngmt reported 0.39% of its portfolio in Deere & Company (NYSE:DE). 265 are held by Cornerstone. XNCR's SI was 2.67 million shares in October as released by FINRA. The company's stock had a trading volume of 1,110,340 shares. Moreover, Virginia Retirement Sys Et Al has 0.2% invested in Quest Diagnostics Inc (NYSE:DGX) for 145,200 shares.

(DGX) Shares now down at $92.05 Quest Diagnostics Reports Third Quarter…